Press release
Anemia In Elderly Market Analysis Highlights Growth To $4.59 Billion By 2030 At 8.9% CAGR
Anemia In Elderly Market
Projected Market Value of the Anemia in Elderly Sector by 2030
The anemia in elderly market is forecasted to experience robust expansion, reaching a value of $4.59 billion by 2030, supported by a compound annual growth rate (CAGR) of 8.9%. This upward trajectory is fueled by several critical factors, including the increasing demand for tailored anemia treatments, wider acceptance of long-acting injectable medications, a heightened focus on healthcare for aging populations, growth in outpatient anemia care services, and improved diagnostic screening specifically targeted at elderly patients. Key trends anticipated throughout the forecast period involve greater use of combination therapies, rising application of injectable iron formulations, prioritization of early anemia detection among seniors, growth in home-based treatment solutions, and stronger management strategies for anemia linked to chronic diseases.
The anemia in elderly market size has grown strongly in recent years. It will grow from $2.99 billion in 2025 to $3.26 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to aging population growth, increased prevalence of chronic diseases, availability of oral iron supplements, expansion of hospital-based anemia management, rising awareness of nutritional deficiencies.
Download a free sample of the anemia in elderly market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Prominent Organizations Leading the Anemia in Elderly Market
The anemia treatment landscape for the elderly is shaped by a range of influential companies. Noteworthy players include Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, and MegaPro Biomedical Co Ltd.
In a strategic move in February 2025, AstraZeneca, based in the UK, acquired FibroGen, Inc. for $160 million. This acquisition strengthens AstraZeneca's foothold in the Chinese anemia therapy market by obtaining full rights over roxadustat, including its development, manufacturing, and commercialization. FibroGen, a US biopharmaceutical firm, is recognized for pioneering innovative treatments in cancer biology and anemia, making this partnership a significant milestone for AstraZeneca's growth ambitions.
Emerging Innovations and Trends in the Anemia in Elderly Market
Leading companies in the anemia in elderly field are focusing heavily on technological innovation, particularly personalized treatment methods, to enhance therapeutic effectiveness, minimize adverse effects, and improve healthcare delivery overall. Personalized therapies, which customize treatment plans based on individual patient profiles, are becoming increasingly prominent. For example, in March 2024, Indian pharmaceutical firm Cadila Pharmaceuticals introduced Redshot FCM, a new intravenous iron injection designed for patients intolerant to oral iron supplements. This product features an advanced Ferric Carboxymaltose formula, which optimizes iron supplementation by improving absorption and safety, highlighting the sector's commitment to individualized patient care for iron deficiency anemia.
View the full anemia in elderly market report:
https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Detailed Segmentation of the Anemia in Elderly Market
The anemia in elderly market is categorized into several key segments to better analyze trends and demand patterns:
1) Product Type: Tablets and Injectable forms
2) Treatment Options: Iron Supplements, Erythropoietin or Erythrocyte-Stimulating Agents (ESAs), Vitamin B12 Supplements, Folic Acid Supplements
3) Route of Administration: Oral and Parenteral (injectable)
4) End User Channels: Hospital pharmacies, Online pharmacies, and Retail pharmacies
Further breakdown includes:
- Tablets: Iron Supplements, Vitamin B12 Tablets, Folic Acid Tablets, and ESAs Tablets
- Injectables: Iron Injections, Vitamin B12 Injections, ESAs Injections, and Folic Acid Injections
This segmentation provides a comprehensive view of the market's structure, facilitating targeted strategies and a clear understanding of consumer preferences across different treatment modalities.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anemia In Elderly Market Analysis Highlights Growth To $4.59 Billion By 2030 At 8.9% CAGR here
News-ID: 4603314 • Views: …
More Releases from The Business Research Company
Maprotiline Hydrochloride API Market Report 2026 Market Outlook Supported By A F …
The pharmaceutical ingredients sector, especially for mental health treatments, is evolving rapidly as demand for effective and affordable solutions rises. Among these, the maprotiline hydrochloride API market is gaining significant traction, driven by various factors including manufacturing trends and regulatory demands. Here's a detailed look into its projected growth, key players, market segmentation, and emerging trends.
Market Size and Growth Expectations in the Maprotiline Hydrochloride API Market
Forecasts indicate that…
Mammalian Cell Fermentation Technology Market Insights Highlight Segment Expansi …
The mammalian cell fermentation technology sector is poised for significant expansion as advancements in biopharmaceutical production and personalized medicine continue to accelerate. This market is evolving rapidly, driven by increasing demands for biologics and innovative manufacturing techniques, which are reshaping the landscape of drug development and production.
Expected Growth Trajectory of the Mammalian Cell Fermentation Technology Market
The mammalian cell fermentation technology market is forecasted to experience substantial growth, reaching…
Malignant Mesothelioma Market Report Evaluates Growth Drivers, Challenges And Ma …
The market for malignant mesothelioma treatments is poised for notable expansion as innovative therapies and improved diagnostic tools emerge. With growing attention to rare cancers and increasing investments in oncology, this sector is expected to experience robust growth over the coming years. Let's explore the current market size, influential players, evolving trends, and key segments shaping the future landscape of malignant mesothelioma care.
Malignant Mesothelioma Market Size and Growth Projections Through…
Malaria Vaccines Market Report Provides Insights Into Market Evolution And Growt …
The malaria vaccine landscape is on the cusp of remarkable expansion, driven by breakthroughs in science and increasing global efforts to combat this deadly disease. Understanding the market's future size, key contributors, and emerging trends offers valuable insight into how this vital healthcare segment is evolving. Let's explore the projected growth, leading companies, and the innovations shaping the malaria vaccines market.
Projected Market Value and Growth of the Malaria Vaccines Market…
More Releases for Anemia
Chemotherapy-Induced Anemia Market Forecast by Type Mild Moderate Severe and Lif …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chemotherapy-Induced Anemia Market- (By Type of Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC Transfusion, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp Injection, Epoetin Alfa Injection, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)), By Region, Trends, Industry Competition…
Rising Cancer And Anemia Cases Propel Growth In Chemotherapy-Induced Anemia Mark …
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chemotherapy-Induced Anemia Market Size During the Forecast Period?
The Chemotherapy-Induced Anemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Aplastic Anemia Treatment Market - Shaping the Future of Aplastic Anemia Health: …
Newark, New Castle, USA: The "Aplastic Anemia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Aplastic Anemia Treatment Market: https://www.growthplusreports.com/report/aplastic-anemia-treatment-market/8435
This latest report researches the industry structure,…
Anemia Drugs Market 2018 Grow at CAGR of 8.4% to Reach USD 34.7 Billion | By Uni …
Market Research Future Published a Prime research Report on “Global Anemia Drugs Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022
Global Anemia Drugs Market - Segments
Global anemia drugs market has been segmented on the basis of anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia and others. On the basis of route of administration;…
Anemia in Chronic Kidney Disease (Renal Anemia) - Industry Analysis, Trends, and …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Anemia in Chronic Kidney Disease Pipeline Review, H1 2017” to its report offerings. The report provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) (Hematological Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196648
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2017,…
